[{"type": "title", "data": "CARD STEMI Fibrinolytic Therapy - Initial Management"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "For ongoing management, please refer to CARD Post Fibrinolytic Therapy - Ongoing Management (Module)", "value": ""}, {"type": "note", "data": "Refer to ST-Elevation Angina Management Algorithm", "value": ""}, {"type": "category", "data": "Status"}, {"type": "note", "data": "ABSOLUTE CONTRAINDICATIONS:  - Intracranial hemorrhage (any history)  - Ischemic stroke within 3 months EXCEPT acute ischemic stroke within 4.5 hours  - Known structural cerebral vascular lesion (e.g arteriovenous malformation)  - Known malignant intracranial neoplasm (primary or metastatic)  - Suspected aortic dissection  - Active bleeding or bleeding diathesis (excluding menses)  - Significant closed-head or facial trauma within the last 3 months  - Intracranial or intraspinal surgery within the last 2 months  - Severe, uncontrolled hypertension on presentation (SBP above 180 mmHg or DBP above 110 mmHg)", "value": ""}, {"type": "note", "data": "RELATIVE CONTRAINDICATIONS:  - History of chronic, severe, poorly controlled hypertension  - Severe, uncontrolled hypertension on presentation (SBP above 180 mmHg or DBP above 110 mmHg)  - History of prior ischemic stroke greater than 3 months, dementia, or known intracranial pathology not covered in contraindications  - Traumatic or prolonged (greater then 10 minutes) CPR or major surgery (within 3 weeks)  - Recent internal bleeding (within 2 to 4 weeks)  - Non compressible vascular punctures  - Pregnancy  - Active peptic ulcer  - Current use of anticoagulant; the higher the INR, the higher the risk of bleeding", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Neurovital Signs", "value": "checked"}, {"type": "sentence", "data": "q1h for 4 hour, then q4h for 24 hour post fibrinolytic therapy"}, {"type": "category", "data": "Medications"}, {"type": "order", "data": "tenecteplase", "value": ""}, {"type": "sentence", "data": "30 mg, IV, once, drug form: inj, first dose: STAT"}, {"type": "sentence", "data": "35 mg, IV, once, drug form: inj, first dose: STAT"}, {"type": "sentence", "data": "40 mg, IV, once, drug form: inj, first dose: STAT"}, {"type": "sentence", "data": "45 mg, IV, once, drug form: inj, first dose: STAT"}, {"type": "sentence", "data": "50 mg, IV, once, drug form: inj, first dose: STAT"}, {"type": "note", "data": "Ensure patient has received a total dose of ASA 160 mg in past 12 hours", "value": ""}, {"type": "order", "data": "ASA chewable", "value": "checked"}, {"type": "sentence", "data": "160 mg, PO, once, drug form: tab-chew, first dose: STAT"}, {"type": "order", "data": "ASA chewable", "value": ""}, {"type": "sentence", "data": "80 mg, PO, once, drug form: tab-chew, first dose: STAT"}, {"type": "note", "data": "Consider withholding clopidogrel when urgent cardiac surgery is anticipated (within 5 days), as in cases of previously discerned coronary anatomy, clinically significant valvular disease, those suffering mechanical complications of MI, or hemodynamic compromise and/or shock suggestive of multi-vessel CAD that may require urgent open heart surgery.\n\n", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Clopidogrel does not increase the initial success of fibrinolysis (i.e. achievement of normal [TIMI-3] flow), but may improve likelihood of culprit artery patency if fibrinolysis is successful.", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Clopidogrel loading dose is only for patients not previously on clopidogrel for past 7 consecutive days and are 75 years or less", "value": ""}, {"type": "note", "data": "Not previously on clopidogrel and age 75 years or younger", "value": ""}, {"type": "order", "data": "clopidogrel", "value": ""}, {"type": "sentence", "data": "300 mg, PO, once, drug form: tab, first dose: STAT"}, {"type": "note", "data": "On clopidogrel in the past 7 consecutive days OR age 75 years or older", "value": ""}, {"type": "order", "data": "clopidogrel", "value": ""}, {"type": "sentence", "data": "75 mg, PO,  once, STAT, drug form: tab"}, {"type": "note", "data": "Initiate anticoagulation within 5 minutes of fibrinolytic", "value": ""}, {"type": "note", "data": "For patients 75 years or less", "value": ""}, {"type": "note", "data": "Select enoxaparin OR heparin (enoxaparin preferred)", "value": ""}, {"type": "note", "data": "Enoxaparin is CONTRAINDICATED in a patient with a known eGFR of less than 30 mL/min or with suspected severe renal insufficiency. Use with caution and omit IV bolus if age greater than 75 years", "value": ""}, {"type": "note", "data": "Enoxaparin IV bolus and subcutaneous must be ordered together", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, IV, once, drug form: inj, first dose: STAT"}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, subcutaneous, once, drug form: inj, first dose: STAT"}, {"type": "sentence", "data": "100 mg, subcutaneous, once, drug form: inj, first dose: STAT"}, {"type": "note", "data": "For patients older than 75 years", "value": ""}, {"type": "note", "data": "Select fondaparinux OR heparin", "value": ""}, {"type": "note", "data": "Fondaparinux is CONTRAINDICATED if eGFR is less than 30 mL/min; possibility of PCI in next 7 days", "value": ""}, {"type": "order", "data": "fondaparinux", "value": ""}, {"type": "sentence", "data": "2.5 mg, subcutaneous, once, drug form: inj, first dose: STAT"}, {"type": "note", "data": "Heparin", "value": ""}, {"type": "sub phase", "data": "CARD Heparin Infusion Post Fibrinolytic (Module)", "value": ""}, {"type": "note", "data": "Avoid nitroglycerin if any of the following are present:   - SBP below 90 mmHg or if more than 30 mmHg drop from baseline  - Suspected right ventricular infarction  - Recent use of phosphodiesterase inhibitors; within 24 hours for sildenafil [VIAGRA] and vardenafil [LEVITRA]; within 48 hours for tadalafil [CIALIS]", "value": ""}, {"type": "order", "data": "nitroglycerin 0.4 mg/spray spray", "value": ""}, {"type": "sentence", "data": "1 spray, sublingual, q5min, PRN other (see comment), drug form: spray"}, {"type": "order", "data": "nitroglycerin titratable infusion (0.2 mg/mL) in D5W standard", "value": ""}, {"type": "sentence", "data": "Titrate, IV, 10 mcg/min starting rate, 0 mcg/min minimum rate, 200 mcg/min maximum rate, titrate instructions: Titrate by 10 mcg/min, q5min PRN for symptoms of ischemia; maintain SPB above 90 mmHg"}, {"type": "sentence", "data": "50 mg"}, {"type": "order", "data": "morphine PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 1 to 5 mg, IV, q1min, PRN other (see comment), drug form: inj"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "POC CBC", "value": ""}, {"type": "sentence", "data": "Whole Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "POC Hemoglobin", "value": ""}, {"type": "sentence", "data": "once, STAT"}, {"type": "order", "data": "INR", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "POC INR Level", "value": "checked"}, {"type": "sentence", "data": "once, STAT"}, {"type": "order", "data": "PTT", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "Basic Metabolic Panel (Lytes, Urea, Creat, Gluc)", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "POC Basic Metabolic Panel (Lytes, Urea, Creat, Gluc)", "value": ""}, {"type": "sentence", "data": "Whole Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "Troponin I Cardiac High Sensitivity", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "Troponin I Cardiac", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "POC Troponin I", "value": ""}, {"type": "sentence", "data": "Whole Blood, STAT, Collection: T;N, once"}, {"type": "order", "data": "Troponin T Cardiac High Sensitivity", "value": "checked"}, {"type": "sentence", "data": "Blood, STAT, Collection: T;N, once"}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "XR Chest", "value": ""}, {"type": "sentence", "data": "STAT, Reason: Chest Pain, Transport: Portable, Portable Reason: Requires constant monitoring/observation"}, {"type": "order", "data": "Electrocardiogram 12 Lead STAT", "value": ""}, {"type": "sentence", "data": "Reason: Chest Pain"}, {"type": "order", "data": "Conditional Order - One Time", "value": "checked"}, {"type": "sentence", "data": "If/when fibrinolytic therapy is given, then RN to place an order for Electrocardiogram 12 Lead 60 minutes post administration"}, {"type": "note", "data": "Consider rescue PCI 60 minute if patient has any of the following:  - persistent ST elevation (less than 50% resolution) with or without ongoing chest pain or ischemia OR  - development of cardiogenic shock or worsening heart failure OR  - refractory ventricular arrhythmias", "value": ""}, {"type": "order", "data": "Electrocardiogram 15 Lead STAT", "value": ""}, {"type": "sentence", "data": "Reason: Chest Pain, If posterior/Right Ventricular Myocardial Infarction suspected"}, {"type": "category", "data": "Communication Orders"}, {"type": "note", "data": "Ensure an evaluation of Left Ventricular function is acquired prior to discharge", "value": ""}]
